Cargando…

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma

Purpose: AHNAK is originally identified as a giant protein based on the estimated size of approximately 700 kDa. The aim of this study is to identify the role of AHNAK in the pathogenesis of glioma. Methods: We tested AHNAK mRNA level in a panel of six human glioma cell lines, and in 30 cases of nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zijin, Xiao, Songhua, Yuan, Xianrui, Yuan, Jian, Zhang, Chi, Li, Haoyu, Su, Jun, Wang, Xiangyu, Liu, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604443/ https://www.ncbi.nlm.nih.gov/pubmed/28928883 http://dx.doi.org/10.7150/jca.20277

Ejemplares similares

AHNAKs roles in physiology and malignant tumors
por: Zhang, Shusen, et al.
Publicado: (2023)

Valproic Acid Protects Primary Dopamine Neurons from MPP(+)-Induced Neurotoxicity: Involvement of GSK3β Phosphorylation by Akt and ERK through the Mitochondrial Intrinsic Apoptotic Pathway
por: Zhang, Chi, et al.
Publicado: (2017)

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway
por: Cai, Yanlin, et al.
Publicado: (2021)

The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022)

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
por: Zhang, Shusen, et al.
Publicado: (2020)

AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas: AHNAK2 is a biomarker for adenocarcinomas
por: Xu, Meng, et al.
Publicado: (2022)

Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021)

AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R
por: Li, Kang, et al.
Publicado: (2022)

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2017)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019)

SORBS1 serves a metastatic role via suppression of AHNAK in colorectal cancer cell lines
por: Cho, Woo-Cheol, et al.
Publicado: (2020)

Treatment Strategy for Petroclival Meningiomas Based on a Proposed Classification in a Study of 168 Cases
por: Zhao, Zijin, et al.
Publicado: (2020)

AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK
por: Xiang, Xiao, et al.
Publicado: (2021)

Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway
por: Lee, I H, et al.
Publicado: (2014)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma
por: Peng, Rui, et al.
Publicado: (2019)

Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition
por: Zhang, Zhiwen, et al.
Publicado: (2019)

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021)

Protein kinase B phosphorylates AHNAK and regulates its subcellular localization
por: Sussman, Joshua, et al.
Publicado: (2001)

Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
por: Koguchi, Dai, et al.
Publicado: (2021)

Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition
por: Sohn, Mira, et al.
Publicado: (2018)

Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma
por: Xie, Zhenyu, et al.
Publicado: (2020)

Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV‐related liver diseases
por: Sun, Libo, et al.
Publicado: (2018)

Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis
por: Wu, Changwu, et al.
Publicado: (2019)

Ahnak is required to balance calcium ion homeostasis and smooth muscle development in the urinary system
por: Lee, Jong-Min, et al.
Publicado: (2023)

The human gene AHNAK encodes a large phosphoprotein located primarily in the nucleus
Publicado: (1993)

Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release
por: Zacharias, Ute, et al.
Publicado: (2011)

MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2
por: Li, Jian, et al.
Publicado: (2021)

LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas
por: Su, Jun, et al.
Publicado: (2019)

Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
por: Yuan, Qing, et al.
Publicado: (2021)

Ahnak depletion accelerates liver regeneration by modulating the TGF-β/Smad signaling pathway
por: Yang, Insook, et al.
Publicado: (2022)

Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p
por: Li, Haoyu, et al.
Publicado: (2021)

Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients
por: Ouyang, Qing, et al.
Publicado: (2015)

MicroRNA-93-5p promotes epithelial-mesenchymal transition in gastric cancer by repressing tumor suppressor AHNAK expression
por: Shen, Erdong, et al.
Publicado: (2020)

Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression
por: Tang, Guodong, et al.
Publicado: (2016)

AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture
por: Benaud, Christelle, et al.
Publicado: (2004)

AHNAK deficiency promotes browning and lipolysis in mice via increased responsiveness to β-adrenergic signalling
por: Shin, Jae Hoon, et al.
Publicado: (2016)

AHNAK is downregulated in melanoma, predicts poor outcome, and may be required for the expression of functional cadherin-1
por: Sheppard, Hilary M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g1q5onra9lq4rpbj5cvecmboo2